Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3
Hongliang Zhang1,2, Kang Yang1,2, Tingting Ren1,2
1Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, People's Republic of China.
Abstract:
Aberrantly expressed miRNAs play a crucial role in the development of multiple cancer types, including chordoma. However, the detailed molecular mechanisms are unclear and need to be elucidated. In this study, miRNAs were screened by miRNA array analysis and then confirmed by real-time PCR analysis. We found that miR-16-5p was significantly downregulated in chordoma, and overexpression of miR-16-5p suppressed chordoma cell proliferation, invasion and migration in vitro and in vivo and correlated with the upregulated expression of E-cadherin and downregulated expression of N-cadherin and vimentin. Furthermore, Smad3 was identified as a target of miR-16-5p, and Smad3 was highly expressed in chordoma tissues. Further research showed that knockdown of Smad3 had an effect similar to that of overexpression of miR-16-5p in chordoma cells. Our findings demonstrate that miR-16-5p plays a tumor suppressor role in chordoma progression by targeting Smad3, which could provide a promising prognostic and therapeutic strategy for chordoma treatment.
Insights
MicroRNA-16-5p (miR-16-5p) acts as a tumor suppressor in chordoma by inhibiting cell growth and metastasis. Targeting Smad3 with miR-16-5p offers a potential new treatment strategy for chordoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant microRNA (miRNA) expression is implicated in various cancers, including chordoma.
- The precise molecular mechanisms underlying miRNA involvement in chordoma progression remain largely undefined.
Purpose of the Study:
- To investigate the role of specific miRNAs in chordoma development.
- To elucidate the molecular targets and pathways regulated by key miRNAs in chordoma.
Main Methods:
- miRNA array analysis for initial screening.
- Real-time PCR for confirmation of miRNA expression.
- In vitro and in vivo assays to assess cell proliferation, invasion, and migration.
- Western blotting to analyze protein expression (E-cadherin, N-cadherin, vimentin, Smad3).
- Gene knockdown experiments (Smad3).
Main Results:
- miR-16-5p was significantly downregulated in chordoma tissues.
- Overexpression of miR-16-5p inhibited chordoma cell proliferation, invasion, and migration.
- miR-16-5p modulated the expression of epithelial-mesenchymal transition markers (upregulated E-cadherin, downregulated N-cadherin and vimentin).
- Smad3 was identified as a direct target of miR-16-5p and was highly expressed in chordoma.
- Knockdown of Smad3 mimicked the tumor-suppressive effects of miR-16-5p.
Conclusions:
- miR-16-5p functions as a tumor suppressor in chordoma by targeting Smad3.
- The miR-16-5p/Smad3 axis represents a potential therapeutic target for chordoma treatment.
- This study provides insights into novel prognostic and therapeutic strategies for chordoma.
More Related Videos
Related Concept Videos
Cattell's 16 Personality Factors
In contrast, source traits are the...
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation
Enzyme Inhibition

